By Karnav Shah | 
November 9, 2021  | 
By Karnav Shah 
November 9, 2021  

The cryptocurrency world is growing at a fast pace, and everyone wants to be a part of it. Natural bioactive molecule manufacturer Xanto entered the blockchain space with its product Xanthohumol. The company produces the purest form of Xanthohumol in the world. The company has embraced blockchain technology for several reasons. With the help of blockchain technology, each batch of a product can easily be traced throughout the production process.

XAN is the utility token for Xanto. The XAN crypto-currency token is built with the TRC-20 standard using TRON Blockchain technology. The XAN token is used to acquire Xanthohumol. To ensure investor stability, the company used the TRON Ecosystem. TRON’s blockchain charges a very low commission on TRC20 transfers. Furthermore, the TRON ecosystem had more transactions than the Ethereum ecosystem in mid-2021. 

The company token was launched on 15 September 2021 and priced at $2. The company estimates that the XAN price will increase by $0.21 per week and will reach $7 within 24 weeks. This means that those who purchased the XAN token during the presale or shortly after launch will reap the most benefits. The user can purchase XAN tokens after KYC verification is complete. To purchase XAN tokens, the user should have a TRX address in the TRON network.

XAN TOKEN KEY BENEFITS

Backed by the commodity Xanthohumol, The standard target price of the XAN token is 7USDT/XAN. We nonetheless promote the purchase of the tokens at the initial price of 2USDT/XAN, during the period 24 weeks from the start of the program. The prices though will continue to proportionally increase each week to the target price of 7 USDT/XAN. 

XAN is built on a robust Tron blockchain, owing to its low fees and higher efficiency. In order to be a Xan token buyer make sure you have a TRX address, or just simply grab them by setting them up on the Tronlink.org website. 

What’s more, the investors will also be able to exchange XAN for the commodity (Xanthohumol) through classic forward or prepaid forward contracts. 

The company is also researching new ways to use xanthohumol in new products. R&D team of the company conducts these studies to demonstrate its results to potential manufacturers. As a part of the Made in Poland 2021 program, XANTO won the award in July 2021 “for continuous development, promoting Polish products in the international arena and a significant impact on the shape of the national economy”. The company’s sole objective is to achieve new heights while providing quality benefits to its investors.

Explaining what’s impressive about the innovative approach of the Xanto project, Editor in Chief at Cryptonaire Weekly Mr Karnav Shah said: “Xanto is a manufacturer of natural bioactive molecules which are used in the medical treatment of humans and animals. At Platinum Crypto Academy we are glad to have introduced our readers to such a brilliant initiative. I’m sure we will have more from the Xanto project for our readers.”

Hopefully, you have enjoyed today’s article for further coverage please check out our Crypto Blog Page Thanks for reading! Have a fantastic day! Live from the Platinum Crypto Trading Floor.

Earnings Disclaimer: The information you’ll find in this article is for educational purpose only. We make no promise or guarantee of income or earnings. You have to do some work, use your best judgement and perform due diligence before using the information in this article. Your success is still up to you. Nothing in this article is intended to be professional, legal, financial and/or accounting advice. Always seek competent advice from professionals in these matters. If you break the city or other local laws, we will not be held liable for any damages you incur.